fidanacogene elaparvovec-dzkt | Clinical Trials Search

找到 33 条关于 “fidanacogene elaparvovec-dzkt”

需要更精确的结果？

可按分期、招募状态、国家、申办方、年龄和研究类型筛选。

高级筛选临床试验

进行中（未招募）

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

计划入组 51 人 · 首次发布于 2019 年 3 月 4 日

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

计划入组 173 人 · 首次发布于 2022 年 10 月 6 日

进行中（未招募）

A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants

计划入组 13 人 · 首次发布于 2021 年 5 月 26 日

Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

计划入组 56 人 · 首次发布于 2023 年 7 月 27 日

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

计划入组 35 人 · 首次发布于 2023 年 8 月 22 日

JPRN-UMIN000001592

Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery(a randomized, double-blind, multi-center, placebo-controlled study)

计划入组 400 人

JPRN-UMIN000003103

Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following resection of liver cancer(a randomized, double-blind, multi-center, placebo-controlled study)

计划入组 200 人

JPRN-UMIN000001793

Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery (a randomized, double-blind, multi-center, placebo-controlled study) Additional study:Gastrointestinal transit time as an indicator

计划入组 100 人